Targeting CD38/ ADP-ribosyl cyclase as a novel therapeutic strategy for identification of three potent agonists for leukopenia treatment

Leukopenia is the most common side effect of chemotherapy and radiotherapy. It potentially deteriorates into a life-threatening complication in cancer patients. Despite several agents being approved for clinical administration, there are still high incidences of pathogen-related disease due to a lac...

Ausführliche Beschreibung

Bibliografische Detailangaben

Hauptverfasser:	Yuanzhi Liu, Linwei Zhang, Long Wang, Xiaoqin Tang, Shengli Wan, Qianqian Huang, Mei Ran, Hongping Shen, Yan Yang, Sawitree Chiampanichayakul, Singkome Tima, Songyot Anuchapreeda, Jianming Wu
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	Elsevier 2024-02-01
Schriftenreihe:	Pharmacological Research
Schlagworte:	Virtual screening ADP-ribosyl cyclase Ziyuglycoside II Brevifolincarboxylic acid 3,4-dihydroxy-5-methoxybenzoic acid Leukopenia
Online-Zugang:	http://www.sciencedirect.com/science/article/pii/S1043661824000124
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!